Lenses linked to increased inflammatory markers

Article

Tear levels of inflammatory markers increase in patients who wear corneal refractive therapy lenses, compared to those who wore silicone-hydrogel lenses or no lenses.

Tear levels of inflammatory markers increase in patients who wear corneal refractive therapy lenses, compared to those who wore silicone-hydrogel lenses or no lenses.

A team led by Dr Javier González-Pérez, Ocular Surface and Contact Lens Research Laboratory, Faculty of Optics and Optometry, University of Santiago de Compostela, Spain, compared 60 participants in a prospective, case-controlled study.

Of the subjects studied, 28 wore a silicone-hydrogel lens continuously for 30 nights and 32 wore a corneal refractive therapy lens on an overnight basis. There were also 32 control subjects included in the investigation.

Twelve months after initial lens fitting tear samples were obtained and assayed using ELISA cytokines IL-6 andIL-8, matrix metalloproteinase 9 (MMP-9) and epidermal growth factor (EGF).

EGF significantly rose after 12 months for both lenses and IL-6, IL-8 and MMP-9 only increased after corneal refractive therapy. Inflammatory response for corneal refractive therapy patients was linked to the degree of myopia and the presence of corneal staining.

An increased level of MMP-9 and EGF was associated with the presence of corneal-pigmented arch in those who wore corneal refractive therapy lenses.,/p>

The abstract was recently published in the British Journal of Ophthalmology.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.